Exposure of Siberian hamsters to short photoperiod for 14 weeks induces ovarian regression. Subsequent transfer to long photoperiod restores ovarian function, and 2 weeks of photostimulation increases plasma estradiol (E 2 ), antral follicles, and corpora lutea (CL). Because tissue remodeling involved with photostimulated ovarian recrudescence is associated with differential expression of matrix metalloproteinases (MMPs), we hypothesized that inhibiting MMP activity using a broad-spectrum in vivo MMP inhibitor, GM6001, would curtail recrudescence. One group of hamsters was placed in long days (LD; 16 h light:8 h darkness) for 16 weeks. Another group was placed in inhibitory short days (SD; 8 h light:16 h darkness) for 14 weeks. A third group was placed in SD for 14 weeks and transferred to LD for 2 weeks to stimulate recrudescence. During weeks 14-16, animals were either not treated or treated daily with i.p. injections of GM6001 (20 mg/kg) or vehicle (DMSO). GM6001 reduced gelatinase activity and decreased immunohistochemical staining for MMP1, MMP2, and MMP3 compared with vehicle. No differences between controls, vehicle, or GM6001 treatment were observed among LD animals, despite a trend toward reduction in CL and E 2 with GM6001. Although SD reduced ovarian function, photostimulation of transferred controls increased uterine mass, plasma E 2 , appearance of antral follicles, and CL. With GM6001 treatment, photostimulation failed to increase uterine mass, plasma E 2 , antral follicles, or CL. These data show, for the first time, that in vivo GM6001 administration inhibits MMP activity in hamster ovaries during photostimulation, and indicate that this inhibition may impede photostimulated recrudescence of ovaries. This study suggests an intriguing link between MMP activity and return to ovarian function during photostimulated recrudescence.
Introduction
To maximize survival of parent and offspring, many temperate mammals limit reproduction to times when resources are more plentiful. Seasonal limitation of reproduction can be regulated by environmental cues such as food availability, ambient temperature, and photoperiod. Siberian hamsters (Phodopus sungorus) experience a physiological loss and return of reproductive function mediated by photoperiod exposure that can be recreated in the laboratory. Exposure to short photoperiod causes extended periods of melatonin release, triggering a cascade of hormonal changes that suppress activity of the hypothalamic-pituitary-gonadal (HPG) axis, reducing synthesis and secretion of pituitary gonadotropins, and eventually leading to regression of the ovaries and inhibition of reproductive function (Schlatt et al. 1993 , Moffatt-Blue et al. 2006 . Exposure to 12-14 weeks in short (8 h light:16 h darkness per day; short day (SD)) photoperiod is sufficient to induce regression of the ovaries, anovulation, and decreased estradiol (E 2 ) production (Schlatt et al. 1993 , Moffatt-Blue et al. 2006 , Salverson et al. 2008 . Reproductively, regressed hamsters are characterized by the absence of corpora lutea (CL) in the ovaries, decreases in uterine mass and plasma concentration of E 2 , and the presence of eosiniphilic terminal atretic follicles, structures typically found only in regressed ovaries (van den Hurk et al. 2002 , Moffatt-Blue et al. 2006 , Kabithe & Place 2008 . Once transferred to long day (LD) photoperiods of 16 h light:8 h darkness per 24 h period, female hamsters will rapidly regain reproductive function (Salverson et al. 2008 . LD photostimulation increases the number of CL within 1 week, decreases the presence of terminal atretic follicles by 2 weeks, and restores plasma E 2 concentrations by 4 weeks (Salverson et al. 2008) . These changes require significant ovarian remodeling at the cellular level.
In the breeding season, ovaries undergo continuous tissue remodeling during follicular growth, maturation, and ovulation. A family of proteins known as the matrix metalloproteinases (MMPs) play an important role in this process by clearing the way for new growth by cleaving ovarian tissue components, releasing growth factors, and contributing to the degradation of the extracellular matrix (Curry & Osteen 2003 , Smith et al. 2005 . Although the role of these proteases in ovulation and development of CL is not fully defined (Liu et al. 2006 , Wahlberg et al. 2007 ), MMPs and their endogenous inhibitors (tissue inhibitors of MMPs) are differentially expressed in the cycling ovary and uterus (Fata et al. 2000 , Curry & Osteen 2001 , Vrooman & Young 2010 , and are implicated in regulation of estrus and menstrual cycles.
Because differential expression of MMPs also occurs during ovarian recrudescence (Salverson et al. 2008) , we hypothesized that an inhibition of MMP activity would impede LD-stimulated ovarian return to function. MMPs share a basic structural organization and are dependent on zinc for their activity (Bauvois 2001) . GM6001, also known as galardin, ilomastat, or N-((2R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide, is a peptide hydroxamate broad-spectrum inhibitor of MMPs, which works in vivo by chelating the active site zinc atom (Grobelny et al. 1992 ; Millipore BIOMOL Research Laboratories 2009, GM6001 product data sheet). We specifically hypothesized that in vivo administration of GM6001 would curtail the effects of photostimulated recrudescence during 2 weeks of LD stimulation following chronic SD exposure.
Results

Reproductive organ masses
Ovarian mass did not differ between LD-exposed no-treatment controls (LD) and the LD vehicle (LDV), LD GM6001 (LDG), post-transfer, and post-transfer vehicle (PTV) groups (Fig. 1) . In contrast, ovarian mass was reduced 1.8-2.0-fold with SD exposure and following the GM6001 treatment during post-transfer exposure to LD photoperiod (PTG) as compared with LD, PT, and PTV controls (P!0.05; Fig. 1A ). Uterine mass remained unchanged across the LD, LDV, LDG, PT, and PTV groups (PO0.05; Fig. 1B) , however, decreased in the SD (3.0-fold) and PTG groups (2.6-fold) as compared with LD controls, and declined 2.5-and 2.2-fold as compared with the PTV females respectively (P!0.05; Fig. 1B ).
Follicle counts
Ovarian histology was evaluated and follicles were quantified for the number of preantral, antral, CL, atretic, and terminal atretic follicles (Fig. 2) . High numbers of CL, antral, and preantral follicles were noted in LD controls, as expected ( Fig. 2A ). Active ovaries with preantal and antral follicles were also observed in the LDG females treated with GM6001 (Fig. 2B ). Exposure to SD conditions for 14 weeks reduced the number of CL and antral follicles, and increased the numbers of eosiniphilic terminal atretic follicles as compared with LD females (Fig. 2C) . Subsequent transfer to LD conditions for 2 weeks (PT) increased CL and antral follicles, and eliminated terminal atretic follicles (Fig. 2D) . In contrast, post-transfer females treated with GM6001 (PTG) showed low numbers of CL and antral follicles, and high numbers of terminal atretic follicles (Fig. 2E) . Vehicle administration had no apparent effect on LD or PT females; no general differences were observed (data not shown, but quantified below).
When quantified, follicle counts did not vary significantly between the LD, LDV, LDG, PT, and PTV groups for any follicle type (Fig. 3) . The number of preantral follicles did not differ significantly between any groups (Fig. 3A) . Antral follicle numbers were highest in LD, LDV, LDG, PT, and PTV, and there were no differences across these groups (PO0.05; Fig. 3B ). In contrast, no antral follicles were noted in any SD or PTG female, a 2.5-fold decrease as compared with LD, LDG, and PT ovaries (P!0.05; Fig. 3B ). LD and LDV females had high number of CL; treatment with GM6001 did not MeanGS.E.M. (A) ovarian mass (g) and (B) uterine mass (g) in Siberian hamsters exposed to long day (LD, nZ9; LDV, nZ9; LDG, nZ9); animals transferred from short day (SD) to LD photoperiod (PT, nZ4; PTV, nZ7); animals exposed to SD photoperiod alone (SD, nZ4) and animals treated with GM6001 during exposure to LD photoperiod (PTG, nZ9). Groups with different letters are significantly different (P!0.05).
significantly decrease CL numbers in the LDG group, although a declining trend was apparent (PO0.05; Fig. 3C ). CL were not present in SD females, a significant decrease as compared with the LD, LDV, LDG, PT, and PTV groups (P!0.05; Fig. 3C ). Transfer to LD photostimulation restored ovulatory events in PT and PTV females; these females had CL numbers no different from those observed in LD controls (PO0.05; Fig. 3C ). Interestingly, CL numbers were reduced 11-fold in PTG females compared with LD ovaries, and 10-fold compared with PTV (P!0.05; Fig. 3C ). When quantified, no differences were noted in standard atretic follicles (PO0.05, data not shown); however, terminal atretic follicles characteristic of SD regressed hamster ovaries were noted only in the SD and PTG groups, with significant differences observed in SD and PTG females as compared with all other groups (P!0.05; Fig. 3D ).
Blood plasma E 2 concentration
Concentrations of plasma E 2 for LD animals were within typical values for reproductively cycling females of this species (Moffatt-Blue et al. 2006 , Salverson et al. 2008 . E 2 values did not differ with vehicle or GM6001 administration in LD females, despite a downward trend in the LDG group (PO0.05; Fig. 4 ). Exposure to inhibitory photoperiod reduced plasma E 2 values 11.5-fold in the SD group as compared with LD levels (P!0.05; Fig. 4) . Plasma E 2 concentrations in PT and PTV females were restored to levels no different from those observed in LD females: PT and PTV E 2 concentrations did not differ as compared with all other groups (PO0.05; Fig. 4 ). In contrast, treatment with GM6001 prevented the increase in E 2 concentrations observed in the PT group; values in PTG females were 1.5-2.0-fold lower as compared with PT and PTV animals, and 2.5-fold lower (P!0.05) as compared with the LD and LDV groups (Fig. 4) .
MMP expression and activity
Treatment with GM6001 significantly reduced the activity of active MMP2 ( Fig. 5B ) and MMP9 ( Fig. 5C ) in the uterine tissue as compared with the PTV group (P!0.05). There was no difference in MMP2 or MMP9 activity between the LDV and PTV groups (PO0.05).
As an additional control to demonstrate that GM6001 reduces MMP activity, immunostaining levels were quantified for pro/active MMP1, MMP2, and MMP3 across the PTV and PTG groups ( No staining was noted in controls processed in parallel without primary antibody (Fig. 6 ). Finally, because GM6001 affects MMPs at the activity level, mRNA expression of MMP9 and MMP2 was examined in the ovarian tissue using real-time PCR and species-specific primers to ensure that a global reduction in transcription had not occurred. The expression of MMP2 and MMP9 mRNA remained unchanged between the PTV controls and GM6001-treated (PTG) groups, as expected (PO0.05, data not shown).
Discussion
This study is the first to demonstrate an alteration of normal ovarian function during photoperiod-mediated recrudescence as a result of reducing MMP activity. While transfer from inhibitory short photoperiods into stimulatory long photoperiods restored reproductive function via increased ovarian and uterine mass, follicular development, ovulation and E 2 production, treatment of regressed females with MMP inhibitor GM6001 prevented these increases during photostimulation. Indeed, regressed females treated with MMP inhibitor maintained an SD phenotype post-transfer to LD: reduced follicle development, ovulation, E 2 concentrations, ovarian and uterine mass, and the presence of terminal atretic follicles are the characteristic of regressed ovaries. Because an inhibition of MMPs using GM6001 impedes ovarian recrudescence at 2 weeks of treatment, our study demonstrates a potential role for MMPs during photostimulated return of ovarian function in Siberian hamsters. To our knowledge, these data provide the first evidence that ovarian function during photostimulated recrudescence can be impeded via inhibition of a protease class at the level of the reproductive organs (ovary, uterus). MMP inhibition was demonstrated using gelatin zymography and immunohistochemistry. In addition to ovarian tissue, uterine tissue was used for these control experiments because 1) the uterus is a target organ of the ovaries and is an excellent measure of reproductive function, and 2) ovarian tissue is limited (3-5 mg tissue for the SD and PTG groups). GM6001 works at the protein level, inhibiting MMP activity via chelation of the active site zinc atom (Grobelny et al. 1992) ; therefore, zymography was critical to show a reduction in actual MMP activity, and active forms of both MMP2 and MMP9 were significantly reduced following GM6001 treatment (Fig. 5) . Similarly, all primary antibodies used for immunohistochemical staining recognized both pro-form and active form of MMPs; GM6001 inhibits Plasma estradiol concentrations (pg/ml) in recrudescing Siberian hamsters. MeanGS.E.M. plasma estradiol concentrations (pg/ml) in Siberian hamsters exposed to long day (LD), short day (SD), or post-transfer (PT) from SD to LD photoperiod with no treatment (LD, SD, and PT), or with treatment with vehicle (LDV and PTV) or GM6001 (LDG and PTG). Groups with different letters are significantly different (P!0.05); n per group the same as listed in Fig. 1. activation of MMPs and thus a potential reduction of MMP immunostaining, rather than an absence, was predicted. Staining for collagenase (MMP1), gelatinase (MMP2), and stromelysin (MMP3) was significantly reduced with use of the GM6001 inhibitor (Fig. 6 ). While it is not known whether the reduction in immunostaining reflects a decline in the pro-form, active form, or both, GM6001 administration did induce a decrease in these MMPs. As an additional demonstration of efficacy of GM6001 at the level of activity, real-time PCR results showed that the expression of MMP9 and MMP2 mRNA remained unchanged between the vehicle and GM6001-treated groups. This was as expected, since GM6001 inhibits MMP activity and not mRNA expression. The inhibition of ovarian function observed in PTG females did not appear to result from systemic influences of the inhibitor on overall health of the hamsters. Compared with related studies using GM6001 in vivo, the 20 mg/kg body weight dose used in this study was in the mid to low range (Liu et al. 2006) . Animals treated with GM6001 in this study showed no visible signs of distress during the 2-week treatment period, regardless of being in the LDG or PTG groups.
Administration of GM6001 in the control (cycling) animals did not affect ovarian or uterine mass, though masses did not differ significantly in this group from either PTG or SD females (Fig. 1) . Similarly, GM6001 administration to LD females did not affect preantral or antral follicle counts as compared with LD or LDV controls, although it was noted that several antral follicles were counted as atretic in the GM6001-treated group, as opposed to the more typically observed secondary follicle undergoing atresia (Fig. 2) . While CL numbers in the LDG group did not significantly decline as compared with LD females, CL number appeared to trend downward, with a 56% drop as compared with LD controls, which could reflect a possible decline in ovulation or CL function when MMPs are inhibited in LD control hamsters (post hoc ANOVA comparing only LD, LDV, LDG CL numbers, PZ0.06). Plasma E 2 concentrations also showed a nonsignificant decline in LDG females, with levels 40% lower than LD controls. A minor (20%), but significant, decrease in ovulation efficiency does occur in pregnant mares serum gonadotrophin/human chorionic gonadotrophin-stimulated immature C57BL/6 mice administered GM6001 at a dose of 100 mg/kg (Liu et al. 2006) , although no differences were observed in number of CL formed (Wahlberg et al. 2007) . These studies used a higher dose than the 20 mg/kg used in this study, and concluded that MMPs may not be obligatory for ovulation and CL development in mice (Liu et al. 2006 , Wahlberg et al. 2007 ). However, because MMPs are expressed and differentially regulated in the ovary during follicle development, ovulation, and CL formation/degradation (Curry & Osteen 2003 , Vrooman & Young 2010 , they may play a role in normal ovarian function that could be potentially teased out with a dedicated dose-response study using GM6001 (or other more specific inhibitors, such as gelatinase inhibitor SB3T) and LD control females. It is also likely that the MMPs inhibited with GM6001 are just one part of a large array of proteases and related proteins that mediate the tissue remodeling of folliculogenesis. At the low dose administered, however, no significant changes were noted between LD females in the control, vehicle, and GM6001 groups. In contrast, inhibition of MMPs in regressed females exposed to LD photostimulation retarded resumption of ovarian function, including mass, folliculogenesis, ovulation, and E 2 production. After transfer to LD photoperiod for 2 weeks, hamsters treated with GM60001 inhibitor had ovaries that resembled regressed SD ovaries, suggesting that MMPs may play a more prominent role in the tissue remodeling required for recrudescence, and that regulation of this remodeling may differ from that in normal ovarian cycling. Because MMPs play key roles in the rapid growth associated with tumorigenesis (Kessenbrock et al. 2010) , their function may be more prominent during photostimulated ovarian restoration. Alternatively, regressed ovaries may be more sensitive to MMP inhibition, and differential expression of MMPs noted during photostimulated recrudescence (Salverson et al. 2008 ) may simply reflect a return to normal low levels of MMP action. Because natural intra-ovarian MMP activity is regulated at the level of transcription, translation, secretion, and via activators and inhibitors, MMP involvement in ovarian recrudescence includes more than just the MMPs inhibited by GM6001. Gonadotropins and sex steroid hormones can regulate MMP activity ( Jo et al. 2004 , Young & Stouffer 2004 , and both SD exposure and recrudescence alter FSH and plasma E 2 in Siberian hamsters (Schlatt et al. 1993 , Moffatt-Blue et al. 2006 . In turn, MMP activity can influence steroid synthesis in gonadal tissue (e.g. Nothnick 2003 , Evaul & Hammes 2008 and, in this study, inhibition of MMP activity influenced E 2 production in the recrudescing ovary. While the decrease in E 2 production is concomitant with GM6001 administration, it is not known whether this decline is a result of the direct influence of MMP activity on steroidogenesis, via a possible mechanism of growth factor release, or whether the decline results simply by impeding granulosa cell proliferation and follicle development in general. MMPs can also regulate and activate each other, in particular, the activation of pro-MMP2 via membranebound MT-MMPs (e.g. Butler et al. 1997 , Shofuda et al. 1997 . Ovarian MT-MMP1 (MMP14) peaks during weeks 1-2 of recrudescence (Salverson et al. 2008) , and GM6001 inhibition of this branch of the MMP family may have multiple ramifications at the tissue level.
GM6001 has also been reported to inhibit some proteases in the ADAMs family as well as tumour necrosis factor a in the neural tissue (Galardy et al. 1994 , Leib et al. 2000 ; these additional factors could also impact recrudescence at the level of the ovary. Finally, the transmembrane glycoprotein basinogen stimulates MMP activity and is expressed at high levels in the periovulatory period and during luteinization (Sun & Hemler 2001 , Kanekura et al. 2002 . Owing to the influence MMPs have on recrudescence, basinogen and other MMP inducers may therefore be critical in regulating recrudescence in seasonal breeders. Examining these and other MMP regulators, and how they are controlled by the central HPG axis is critical to understand photostimulated return to ovarian function.
Taken together, the results of this study support the hypothesis that MMP action is needed for timely return to ovarian function. This study is the first to inhibit recrudescence at the level of the ovary, and the first to show that MMP activity is needed for photostimulated restoration of ovarian function. Administration of the MMP inhibitor GM6001 to regressed females effectively reduces follicle development, ovulation, and E 2 plasma concentration, whereas administration of vehicle alone allows return to function that is indistinguishable from recrudescing females receiving no treatment. Further studies to examine the substrates of these proteases, to establish MMP effects on specific indices of recrudescence such as angiogenesis, granulosa cell proliferation, and steroidogenesis, and use of more select inhibitors to specific MMPs are warranted to allow a better understanding of how nonfunctional ovarian tissue can return to a fully functional state following photostimulation.
Materials and Methods
Animals
Adult Siberian hamsters (P. sungorus) were obtained from the colony of Dr Katherine Wynne-Edwards, Queens University (Kingston, ON, Canada). Experiments were carried out at California State University Long Beach (CSULB) in AALAC approved facilities and were conducted in compliance with CSULB and NRC guidelines for the use of laboratory animals, and our approved IACUC protocol. Hamsters were given tap water and food (mixture of Lab Rodent Diet 5001 and Mazuri Hamster & Gerbil Diet, Purina, Brentwood, MO, USA) ad libitum for the duration of the experiment and were housed individually in clear polypropylene cages. Female (nZ51) hamsters were acclimated to an LD (16L:8D) photoperiod for 3 weeks in a room with temperature maintained at 20G2 8C.
To ensure that the females' estrous cycle continues, male hamsters (nZ6) were placed among the females for the duration of the study. One arbitrarily assigned group of female hamsters (nZ24) was then exposed to an SD (8L:16D) photoperiod for 14 weeks in order to ensure full ovarian regression (after Salverson et al. 2008) , while remaining hamsters stayed in LD photoperiod as controls. At the end of 14 weeks, tissue was collected from four female hamsters from the LD and four females from the SD groups. All remaining SD females (nZ20) were transferred back to LD conditions for 2 weeks in order to stimulate recrudescence of ovarian structures, and the LD females remained in long photoperiod (Table 1) .
Treatment with MMP inhibitor
GM6001 (Millipore, Billerica, MA, USA) was dissolved in DMSO for a final concentration of 40 mg/ml. During the 2 weeks following transfer to LD conditions, an experimental group of females (post-transfer week 2 with GM6001 treatment; PTG; nZ9) was treated daily with i.p. injections of GM6001 (20 mg/kg body weight). Controls included an LD GM6001 group receiving the same dose (LDG; nZ9), and both the LDV (nZ9) and PTV (nZ7) groups that were injected with an equal volume of DMSO vehicle. An additional set of control groups was not given injections (LD, nZ9 total collected at 14 and 16 weeks and PT, nZ4; Table 1 ). These selected time points were intended to represent breeding condition (LD), nonbreeding condition (SD), and early recrudescence (PT) respectively (Table 1) . In order to minimize variations in plasma hormone levels and ovarian morphology due to differences in estrous cycle, soiled male bedding was added to the females' cages on the 12th day post-transfer to help synchronize estrous cycles prior to all tissue collection (Dodge et al. 2002 , Moffatt-Blue et al. 2006 , Salverson et al. 2008 .
Tissue collection
On the day of tissue collection, female hamsters were weighed and blood samples were taken retro-orbitally with heparinized capillary tubes following a cocktail of ketamine (20 mg/kg) and xylazine (200 mg/kg) administered i.p. Each hamster was then euthanized via cervical dislocation and reproductive organs were immediately removed, dissected, and weighed. One ovary was fixed in 10% neutral buffered formalin for 7 days, and then transferred to 70% ethanol. The contralateral ovary was flash frozen in liquid nitrogen.
E 2 RIA
Collected plasma was separated by centrifugation (1500 g for 5 min) and stored at K80 8C, until used in the E 2 RIA with Ultra-Sensitive E 2 RIA 125 I double antibody kits (Diagnostic Systems Laboratories, Inc., Webster, TX, USA). Samples were assayed in duplicate and their radioactivity was measured using a gamma counter. A standard curve was generated using a four-parameter logistic curve function (Sigma Plot software, SPSS, Inc., Chicago, IL, USA) and the final hormone concentrations were calculated using the Sigma Plot standard curve analysis function. Assay standards and controls were within the normal limits (Moffatt-Blue et al. 2006) , with a 2.2 pg/ml lower limit of detection.
Ovarian histology and follicle counts
Fixed tissues were dehydrated in a graded series of ethanol solutions and xylenes, and embedded in paraffin wax. Serial paraffin sections of 6 mm thickness were collected from every Gelatin zymography MMP2 and MMP9 activity was assessed by gelatin zymography as described before . In short, frozen uterine tissues were homogenized (1:5) in 0.1 M Tris-HCl (pH 7.6) buffer containing 5 mM CaCl 2 , 150 mM NaCl, 0.05% Brij 35, 0.02% NaN 3 , 1% Triton X-100, and protease inhibitor cocktail and centrifuged for 30 min at 3750 g at 4 8C. Total protein (mg/uterus weight) was determined by the Bradford method (Bio-Rad). Gelatin zymography was performed using precast zymography gels according to manufacturer's directions (Bio-Rad). An aliquot containing 40 mg total protein/lane was applied on the gel. Electrophoresis was conducted at constant voltage (100 V) for 90 min. Gels were then washed in two changes (30 min each) of renaturation buffer (2.5% Triton X-100) and subsequently incubated overnight at 37 8C in zymogram development buffer (50 mM Tris, 200 mM NaCl, 5 mM CaCl 2 , and 0.02% Brij pH 7.5; Bio-Rad). Gels were stained in 0.5% Coomassie blue R250, destained until bands were visible, and photographed. Band density was determined using NIH image software as directed.
MMP immunohistochemistry
Sectioned ovary tissue (nZ4-9 arbitrarily determined females from the PTV and PTG groups) was stained using MMP1, MMP2, and MMP3 antibodies (collagenase, gelatinase, and stromelysin). Primary antibody (Chemicon, Temecula, CA, USA) was applied to the sections in an empirically determined dilution (1:200 for MMP1 and MMP2, 1:400 for MMP3). Biotinylated goat anti-rabbit (MMP1) or horse anti-mouse (MMP2, MMP3) IgG (Vectastain Elite ABC kit; Vector Laboratories, Burlingame, CA, USA) and Vector NovaRed Substrate kit (Vector Laboratories) were used to visualize the antigen. Sections processed in the absence of primary antibody were used as negative controls. Characteristic extent of staining was noted for four to six ovarian sections per animal for each MMP (R180 mm between each section). A semiquantitative analysis of staining extent was conducted and sections were given a numerical value ranging from 0 to 3. A score of 0 indicated no staining; a score of 1 meant faint staining was apparent in at least some of the cells, a score of 2 indicated medium-intense staining that extended throughout the section across multiple follicles, and a score of 3 specified intense staining throughout follicles and some stroma. Results for individual animals were averaged per group and analyzed.
Real-time Q-PCR of MMP2 and MMP9
MMP2 and MMP9 mRNA expression was assessed by qPCR. Total RNA was isolated from ovarian tissue with Trizol (Invitrogen) and cDNA was synthesized exactly as described before (Shahed & Young 2009 ). Primers were designed using Siberian hamster sequences (PCR products extracted and sequenced as described in Shahed & Young 2009 ) and OligoPerfect Designer software (Invitrogen) using the MX3000 cycler manual design criteria (Stratagene Corp., Cedar Creek, TX, USA). Primer sequences used were MMP2 (forward) ATG ATG TCA GCT TCC CCA TC; MMP2 (reverse) ACC TGG ACC CTG AAA CAG TG; MMP9 (forward) ACT TTG GAA ACG CAA ATG GT; MMP9 (reverse) AGT CTC TCA CTG GGG CAG AA. A MX3000 thermocycler was used with Absolute QPCR SYBR green mix (ABgene, Surrey, UK) for Q-PCR. The PCR reaction mix contained 1 ml cDNA (1:5 dilution of cDNA transcribed using 1 mg total RNA) plus 1 ml each of forward and reverse primers (80 nM concentration) plus 6 ml SYBR green mix plus 4 ml water (Promega DNase, RNase, protease free) to a total volume of 12 ml. PCR cycles consisted of 15 min hold at 95 8C (1 cycle), then 40 amplification cycles at appropriate T m (60 8C for MMP2 and 62 8C for MMP9), extension (1 min at 72 8C) followed by dissociation. Nontemplate negative controls and standards were included in each PCR analysis, and PCR products were analyzed on agarose gels to confirm bp size and to visualize potential secondary and nonspecific amplification. For the standard curve, cDNAs from all samples were pooled and a four-point curve was included with each run (for gene of interest and housekeeping genes). The relative amounts of mRNA (arbitrary units) were calculated using standard curves of each gene of interest and housekeeping gene HPRT1, and the ratio of gene of interest to HPRT1 was calculated.
Statistical analysis
All data presented were analyzed using Prism 4 statistical software 240 package (GraphPad Software, Inc., San Diego, CA, USA). One-way ANOVAs were performed on all groups and represented by GS.E.M. If results were significant, using P!0.05, the Neuman-Keuls post hoc test or the Bonferroni multiple comparison test was used to determine differences among experimental groups. To reduce variance in the plasma E 2 concentration analysis, a log transform was used. Owing to the nonparametric nature of the terminal atretic follicle data, the Kruskal-Wallis analysis with Dunn's post hoc multiple comparison test was used for these data. 
